Rainbow Children Medicare IPO

Rainbow Children Medicare (IPO) operates a multi-speciality pediatric, obstetrics and gynaecology hospital chain in India. The company offers a wide range of services such as newborn and pediatric intensive care, pediatric multi-speciality services, pediatric quaternary care, obstetrics and gynaecology, which includes normal and complex obstetric care, and multidisciplinary fetal care, perinatal genetic and fertility care. Rainbow Children’s Medicare operates 14 hospitals and three clinics in six cities, with a total bed capacity of 1,500 beds, as of September 30, 2021. In 1999, the company started its first pediatric speciality hospital in Hyderabad.

Rainbow Children’s Medicare Limited operates on a full-time doctor model ensuring that most of the core specialists are available 24/7 which is particularly important for children’s emergency, neonatal and pediatric intensive care services. As of September 30, 2021, the company had 602 full-time doctors and 1,686 part-time/visiting doctors.

Competitive Strengths:

Ability to conceptualize, create and operate specialized children’s hospitals.
Leading pediatric multi-speciality healthcare chain with strong clinical expertise in managing complex diseases.
Comprehensive perinatal care provider, with synergies between pediatric and obstetrics and gynaecology services.
The hub-and-spoke model provides synergies and ensures better care and access for patients.
Strong track record of growth, and operational and financial performance.
Experienced senior management team with strong institutional shareholder support.

Company Promoters:

Dr. Ramesh Kancharla, Dr. Dinesh Kumar Chirla and Dr. Adarsh Kancharla are the company promoters.

Company Financials:

Particulars	For the year/period ended (Rs in Millions)
	31-Dec-21	31-Dec-20	31-Mar-21	31-Mar-20	31-Mar-19
Total Assets	12,397.56	10,762.22	10,812.67	10,192.37	9,263.96
Total Revenue	7,740.62	4,942.93	6,603.10	7,297.37	5,511.44
Profit After Tax	1,264.13	385.25	395.68	553.40	445.90

Objects of the Issue:

The company propose to utilize the Net Proceeds from the Fresh Issue towards funding the following objects:

The Early redemption of NCDs issued by our Company, in full.
Capital expenditure towards setting up of new hospitals and purchase of medical equipment for such new hospitals.
General corporate purposes.